Jasper Ridge Partners’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.09M | Hold |
95,711
| – | – | 0.03% | 87 |
|
|
2025
Q1 | $1.14M | Hold |
95,711
| – | – | 0.04% | 80 |
|
|
2024
Q4 | $1.8M | Hold |
95,711
| – | – | 0.06% | 72 |
|
|
2024
Q3 | $2.15M | Hold |
95,711
| – | – | 0.06% | 72 |
|
|
2024
Q2 | $2M | Hold |
95,711
| – | – | 0.06% | 76 |
|
|
2024
Q1 | $1.41M | Hold |
95,711
| – | – | 0.04% | 87 |
|
|
2023
Q4 | $988K | Hold |
95,711
| – | – | 0.04% | 85 |
|
|
2023
Q3 | $752K | Hold |
95,711
| – | – | 0.04% | 89 |
|
|
2023
Q2 | $956K | Hold |
95,711
| – | – | 0.05% | 79 |
|
|
2023
Q1 | $850K | Hold |
95,711
| – | – | 0.04% | 89 |
|
|
2022
Q4 | $1.05M | Hold |
95,711
| – | – | 0.06% | 77 |
|
|
2022
Q3 | $1.25M | Sell |
95,711
-2,976
| -3% | -$38.8K | 0.08% | 73 |
|
|
2022
Q2 | $1.25M | Hold |
98,687
| – | – | 0.08% | 75 |
|
|
2022
Q1 | $1.38M | Hold |
98,687
| – | – | 0.07% | 79 |
|
|
2021
Q4 | $2.86M | Buy |
98,687
+2,976
| +3% | +$86.2K | 0.11% | 69 |
|
|
2021
Q3 | $2.87M | Sell |
95,711
-84,769
| -47% | -$2.54M | 0.13% | 71 |
|
|
2021
Q2 | $4.79M | Buy |
180,480
+146,994
| +439% | +$3.9M | 0.24% | 50 |
|
|
2021
Q1 | $1.04M | Buy |
+33,486
| New | +$1.04M | 0.05% | 84 |
|